alpha1a/1d selective adrenergic receptor antagonists (Johnson & Johnson)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namealpha1a/1d selective adrenergic receptor antagonists (Johnson & Johnson)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenoceptor Alpha 1D antagonistsAlpha-1a adrenergic receptor antagonists
TargetsAdrenoceptor Alpha 1DAlpha-1a adrenergic receptor
Therapy Area/IndicationsProstatic Hyperplasia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson Pharmaceutical Research & Development LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohnson & Johnson Pharmaceutical Research & Development LLC
Active IndicationsN/A
Inactive IndicationsProstatic Hyperplasia

Other Information

ATC CodeN/A
Related LinksN/A